Status:
UNKNOWN
Prehabilitation on Fitness, Surgical Outcomes and Mitochondria Functionality in Patients With Esophageal Cancer
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Esophageal Cancer
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
The most often reported complications of patients with resectable esophageal malignancies are pulmonary (25\~57%), which may cause increased intensive care unit utilization, prolonged length of hospit...
Detailed Description
Neoadjuvant chemotherapy has significantly improved patient outcomes. The majority of patients with resectable esophageal malignancies are considered for neoadjuvant treatment. However, esophagectomy ...
Eligibility Criteria
Inclusion
- nonmetastatic esophageal cancer patients.
- V'O2 \< 21ml/min/kg
- abnormality on spirometry.
Exclusion
- Resting heart rate greater than 100 beats per minute
- Atrial fibrillation or flutter
- Poor control of high blood pressure or diabetes
- Patients with peripheral arterial occlusive disease
- Patients with end-stage renal disease
- Patients receiving anticoagulant therapy
- Neurological instability
Key Trial Info
Start Date :
February 25 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2023
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04673968
Start Date
February 25 2020
End Date
November 1 2023
Last Update
February 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Gung Memorial Hospital
Taoyuan District, Taiwan, 333